tetano
Editor, Senior Moderator
CJEM
. 2023 Jan 10.
doi: 10.1007/s43678-022-00440-8. Online ahead of print.
Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study
Katie Lin[SUP] 1 2 [/SUP], Ke Xu[SUP] 3 4 [/SUP], Raoul Daoust[SUP] 5 [/SUP], John Taylor[SUP] 3 [/SUP], Rhonda J Rosychuk[SUP] 6 [/SUP], Jeffrey P Hau[SUP] 3 4 [/SUP], Phil Davis[SUP] 7 [/SUP], Greg Clark[SUP] 8 [/SUP], Andrew D McRae[SUP] #[/SUP][SUP] 9 10 [/SUP], Corinne M Hohl[SUP] #[/SUP][SUP] 3 4 [/SUP]; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers, the Canadian Critical Care Trials Group
Affiliations
Abstract
in English, French
Objective: The primary objective was to quantify the prognostic association between various D-dimer thresholds and 30-day PE diagnosis among emergency department (ED) patients with suspected SARS-CoV-2 infection.
Methods: This was a retrospective study of patients enrolled in the Canadian COVID-19 ED Rapid Response Network (CCEDRRN) registry from March 1, 2020 to July 2, 2021. We included consecutive adults (≥ 18 years) presenting to 49 EDs with chest pain, shortness of breath, hypoxia, syncope, presyncope, or hemoptysis who were tested for both SARS-CoV-2 and D-dimer at index ED visit. The primary outcome measure was the sensitivity, specificity, and negative predictive value of D-dimer test thresholds for the outcome of 30-day PE diagnosis.
Results: Among 10,837 patients included in our study, 404 (3.7%) were diagnosed with PE at 30-days. A standard D-Dimer threshold of 500 ng/mL had a sensitivity of 97.8% (95% confidence interval [CI] 95.8-99.0%), specificity of 40.9% (95% CI 39.9-41.8%), and negative predictive value of 99.8% (95% CI 99.6-99.9%). An age-adjusted D-dimer threshold had a sensitivity of 96.0% (95% CI 93.6-97.7%), specificity of 48.5% (95% CI 47.5-49.4%), and negative predictive value of 99.7% (95% CI 99.5-99.8%). D-dimer testing had slightly lower prognostic performance among SARS-CoV-2 positive compared to SARS-CoV-2 negative patients in predicting 30-day PE diagnosis.
Conclusions: Among ED patients with suspected SARS-CoV-2, the standard 500 ng/mL and age-adjusted D-dimer thresholds were comparable for the prediction of PE at 30-days. The prognostic performance of D-dimer was lower among SARS-CoV-2 positive patients.
Trial registration: Clinicaltrials.gov, NCT04702945.
Keywords: COVID-19; Computed tomography pulmonary angiogram; Coronavirus disease 2019; D-dimer; Pulmonary embolism; SARS-COV-2; Venous thromboembolism.
. 2023 Jan 10.
doi: 10.1007/s43678-022-00440-8. Online ahead of print.
Prognostic association between d-dimer thresholds and 30-day pulmonary embolism diagnosis among emergency department patients with suspected SARS-CoV-2 infection: a Canadian COVID-19 Emergency Department Rapid Response Network study
Katie Lin[SUP] 1 2 [/SUP], Ke Xu[SUP] 3 4 [/SUP], Raoul Daoust[SUP] 5 [/SUP], John Taylor[SUP] 3 [/SUP], Rhonda J Rosychuk[SUP] 6 [/SUP], Jeffrey P Hau[SUP] 3 4 [/SUP], Phil Davis[SUP] 7 [/SUP], Greg Clark[SUP] 8 [/SUP], Andrew D McRae[SUP] #[/SUP][SUP] 9 10 [/SUP], Corinne M Hohl[SUP] #[/SUP][SUP] 3 4 [/SUP]; Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) investigators for the Network of Canadian Emergency Researchers, the Canadian Critical Care Trials Group
Affiliations
- PMID: 36624252
- DOI: 10.1007/s43678-022-00440-8
Abstract
in English, French
Objective: The primary objective was to quantify the prognostic association between various D-dimer thresholds and 30-day PE diagnosis among emergency department (ED) patients with suspected SARS-CoV-2 infection.
Methods: This was a retrospective study of patients enrolled in the Canadian COVID-19 ED Rapid Response Network (CCEDRRN) registry from March 1, 2020 to July 2, 2021. We included consecutive adults (≥ 18 years) presenting to 49 EDs with chest pain, shortness of breath, hypoxia, syncope, presyncope, or hemoptysis who were tested for both SARS-CoV-2 and D-dimer at index ED visit. The primary outcome measure was the sensitivity, specificity, and negative predictive value of D-dimer test thresholds for the outcome of 30-day PE diagnosis.
Results: Among 10,837 patients included in our study, 404 (3.7%) were diagnosed with PE at 30-days. A standard D-Dimer threshold of 500 ng/mL had a sensitivity of 97.8% (95% confidence interval [CI] 95.8-99.0%), specificity of 40.9% (95% CI 39.9-41.8%), and negative predictive value of 99.8% (95% CI 99.6-99.9%). An age-adjusted D-dimer threshold had a sensitivity of 96.0% (95% CI 93.6-97.7%), specificity of 48.5% (95% CI 47.5-49.4%), and negative predictive value of 99.7% (95% CI 99.5-99.8%). D-dimer testing had slightly lower prognostic performance among SARS-CoV-2 positive compared to SARS-CoV-2 negative patients in predicting 30-day PE diagnosis.
Conclusions: Among ED patients with suspected SARS-CoV-2, the standard 500 ng/mL and age-adjusted D-dimer thresholds were comparable for the prediction of PE at 30-days. The prognostic performance of D-dimer was lower among SARS-CoV-2 positive patients.
Trial registration: Clinicaltrials.gov, NCT04702945.
Keywords: COVID-19; Computed tomography pulmonary angiogram; Coronavirus disease 2019; D-dimer; Pulmonary embolism; SARS-COV-2; Venous thromboembolism.